NEXT GENERATION OF RECONSTRUCTIVE SURGERY Perfectly YOU, in all sizes forever THE first company to offer  Permanent results in grafted breast reconstsructions  Fat grafting also for B and C cup-sizes of breasts  A clinically validated method for the cosmetological market  Cultured endogenous fat-derrived hMCs, BoobieCells for the cosmetological market Market* Nordic There are aprox . 11000 breast surgeries performed each year (DK4000, SE5000, NO1000, FI1000) Europe Aprox. 100.000 US Every 4th woman will at one point in life do a breast reconstruction either due to clinical reasons or for cosmetical reasons only. *. The grafting is still a fairly small part, due to the poor success rate Current split is approximately 90%implant 10%grafting . need for additional surgery Business Currently a breast enlargement costs 3-4.000 Eur.  Current market for breast surgery in Europe is approximately 30-40.000.000 Euro=> 3-4.000.000 Euro is grafting Boobicell will address the top segment of this market. A reconstruction w “BoobieCells” will cost twice as much as the current procedure, as one procedure is sufficient 3-4 000 Euro ,for one set of approved BoobieCells We are expecting to reach a marketshare of 3 % on the existing market(in Europe) over a 2 year period. This will give; 0,03 x 100 000= 3000 treatments x 3.000Euro 9.000.000Euro Where are we.. Clinical study at the Rikshospitalet March 2015; Randomied placebo-controlledt study blinded for all participants. 1. 13 healthy participnats 2. Small liposcuction from abdomen 3. Stemcells extracted and expanded in lab 4. Surgery w fat & stemcells What do we already know.. Survival transplanted fat tissue after 4 months. Without stemcells: 16 % With stemcells: 81 % This is our product 1,2 billion BoobieCells This is our team Dusan Raicevic [email protected] Dr Raimund Strehl Raimund @boobiecell.com